News Search Results
Apr 13, 2026, 10:02 ET AMULET BRINGS ELITE PERFORMANCE TO WOMEN'S HORMONAL HEALTH -- BACKED BY INVESTORS INCLUDING MARIA SHARAPOVA AND GABRIELA HEARST
The brand debuts with Daily Cycle Support, a biotechnology-powered supplement designed to support hormonal balance for women and promote energy, mood, strength, and cognitive performance throughout the entire
More news about: Amulet
Apr 13, 2026, 10:00 ET Abcam launches SimpleStep Ignite™ ELISA: an innovative assay platform that combines 50x higher sensitivity and up to 35x wider dynamic range in only 55 minutes
we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every
More news about: Abcam
Apr 13, 2026, 09:00 ET Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
Mr. Todisco brings more than two decades of leadership experience across the pharmaceutical and biotechnology industries, with a strong track record in commercial strategy, corporate development, and entrepreneurship."Joe's deep experience in building
More news about: Airway Therapeutics
Apr 13, 2026, 09:00 ET Airway Therapeutics Appoints Biopharma Leader Joe Todisco to Board of Directors
Mr. Todisco brings more than two decades of leadership experience across the pharmaceutical and biotechnology industries, with a strong track record in commercial strategy, corporate development, and entrepreneurship."Joe's deep experience in building
More news about: Airway Therapeutics
Apr 13, 2026, 08:01 ET Leal Therapeutics Announces Executive Leadership Appointments and Provides Business Update
WORCESTER, Mass., April 13, 2026 /PRNewswire/ -- Leal Therapeutics, Inc. (Leal), a biotechnology company developing neuro-metabolic therapeutics, today announced the appointments of Johannes Tauscher, M.D., as Chief Medical Officer and Raymond
More news about: Leal Therapeutics
Apr 13, 2026, 08:00 ET Sapience Therapeutics Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
TARRYTOWN, N.Y., April 13, 2026 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today
More news about: Sapience Therapeutics, Inc.
Apr 13, 2026, 06:45 ET Lilly's Jaypirca (pirtobrutinib) significantly extended progression-free survival when added to a venetoclax time-limited regimen in patients with previously treated CLL/SLL
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Apr 13, 2026, 06:06 ET Demand for European patents exceeds 200 000 for first time, confirming Europe's competitiveness as a global tech hub
US.In contrast, while medical technology was up 1.3%, some health-related sectors declined, including pharmaceuticals (-6.3%) and biotechnology (-3.3%). This highlights the importance of further strengthening Europe's innovation framework for companies and researchers working in life
More news about: European Patent Office (EPO)
Apr 13, 2026, 06:04 ET Phiusion Labs Inc. Announces Strategic Distribution Partnership with Proteos Biotech S.L. for PBSerum® in the United States and Canada
to introduce science driven solutions to the North American market.About Proteos Biotech S.L.Proteos Biotech S.L. is a Spanish biotechnology company focused on the research and development of advanced recombinant enzymatic technologies, including PBSerum® applications in aesthetic medicine.
More news about: Phiusion Labs Inc.
Apr 13, 2026, 03:52 ET MGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents
unified ecosystem for next-generation research.From Rule-based to AI-drivenAs artificial intelligence continues to reshape biotechnology, genomics is transitioning from proprietary systems toward modular, programmable architectures.MGI introduced the G400RS FluoXpert Vision
More news about: MGI TECH
Apr 13, 2026, 02:17 ET HR Symposium 2026: Inspiring the Next Generation of Industry-Ready Professionals
portfolio of undergraduate, postgraduate, and doctoral programs across Engineering & Technology, Management, Design, Media & Communication, Biotechnology & Healthcare, and Liberal Arts, with specialized pathways in emerging domains such as Artificial Intelligence, Data Science, Digital Business,
More news about: D Y Patil International University
Apr 13, 2026, 00:00 ET AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have
More news about: Anbogen Therapeutics
Apr 13, 2026, 00:00 ET AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead compound, Imofinostat (ABT-301), have
More news about: Anbogen Therapeutics
Apr 10, 2026, 15:47 ET Medpace Holdings Inc. (MEDP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Medpace is a clinical contract research organization (CRO) focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.The Medpace class action lawsuit alleges that defendants throughout the
More news about: Robbins Geller Rudman & Dowd LLP
Apr 10, 2026, 13:03 ET Lupin Launches Dapagliflozin Tablets in the United States
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceutical, Inc.
Apr 10, 2026, 12:52 ET Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®
biology research. Technological advancements in mass spectrometry and nuclear magnetic resonance (NMR), coupled with increasing pharmaceutical and biotechnology investments, are enabling high-throughput metabolite profiling. However, challenges such as high instrumentation costs, lack of standardized protocols,
More news about: Verified Market Research
Apr 10, 2026, 09:55 ET Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
has been treated as a backdrop — the inevitable canvas on which individual diseases are painted. That is beginning to change. A new generation of biotechnology companies is targeting the cellular and molecular drivers of aging itself, and the capital flowing into the space reflects the shift. The longevity
More news about: USA News Group
Apr 10, 2026, 09:46 ET Pendulum Therapeutics Expands Clinical Collaboration to Advance Microbiome Research in Women's Health and Dermatology
Pendulum Therapeutics, a biotechnology company pioneering microbiome science to transform human health, today announced an expanded clinical research collaboration with Mayo Clinic to
More news about: Pendulum Therapeutics
Apr 10, 2026, 09:31 ET IASO Bio Establishes International Partnership with Instituto Butantan to Develop Innovative Therapy for Hematological Cancer
SHANGHAI and NANJING, China and PLEASANTON, Calif., April 10, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), today announced that it has signed a technology licensing agreement with the Instituto Butantan, a leading Brazilian public institution,
More news about: IASO Bio
Apr 10, 2026, 08:30 ET MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity
CAMBRIDGE, Mass., April 10, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that the first patient has been dosed in Part 3 of its Phase 1 clinical
More news about: MetaVia Inc.
Apr 10, 2026, 08:00 ET Lynk Pharmaceuticals Announces NDA Acceptance for Zemprocitinib by NMPA
compares favorably with those of reported JAK inhibitors.About Lynk PharmaceuticalsLynk Pharmaceuticals is a clinical-stage biotechnology company founded by senior drug R&D leaders and executives from Pfizer, Merck, and Johnson & Johnson. The company is dedicated to the discovery
More news about: Lynk Pharmaceuticals Co., Ltd.
Apr 10, 2026, 08:00 ET Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
SUZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ -- Vivatides Therapeutics, a global biotechnology company focused on developing extrahepatic RNA-targeting therapeutics, announced the successful closing of an oversubscribed $54 million Series
More news about: Vivatides Therapeutics
Apr 09, 2026, 21:00 ET ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406
partners to advance better prevention and treatment options for patients worldwide.About ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company
More news about: Arkbio
Apr 09, 2026, 21:00 ET ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406
partners to advance better prevention and treatment options for patients worldwide.About ArkBioArkBio is a commercial-stage biotechnology company focused on the discovery and development of innovative therapeutics for respiratory/lung and pediatric diseases. Founded in 2014, the company
More news about: Arkbio
Apr 09, 2026, 20:00 ET Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies
SHANGHAI, April 9, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today announced the cumulative closing of a pre-IPO financing
More news about: Oricell Therapeutics Holdings Limited